Abstract

BackgroundThe growth potential of the tumor-like Echinococcus multilocularis metacestode (causing alveolar echinococcosis, AE) is directly linked to the nature/function of the periparasitic host immune-mediated processes. We previously showed that Fibrinogen-like-protein 2 (FGL2), a novel CD4+CD25+ Treg effector molecule, was over-expressed in the liver of mice experimentally infected with E. multilocularis. However, little is known about its contribution to the control of this chronic helminth infection.Methods/FindingsKey parameters for infection outcome in E. multilocularis-infected fgl2-/- (AE-fgl2-/-) and wild type (AE-WT) mice at 1 and 4 month(s) post-infection were (i) parasite load (i. e. wet weight of parasitic metacestode tissue), and (ii) parasite cell proliferation as assessed by determining E. multilocularis 14-3-3 gene expression levels. Serum FGL2 levels were measured by ELISA. Spleen cells cultured with ConA for 48h or with E. multilocularis Vesicle Fluid (VF) for 96h were analyzed ex-vivo and in-vitro. In addition, spleen cells from non-infected WT mice were cultured with rFGL2/anti-FGL2 or rIL-17A/anti-IL-17A for further functional studies. For Treg-immune-suppression-assays, purified CD4+CD25+ Treg suspensions were incubated with CD4+ effector T cells in the presence of ConA and irradiated spleen cells as APCs. Flow cytometry and qRT-PCR were used to assess Treg, Th17-, Th1-, Th2-type immune responses and maturation of dendritic cells. We showed that AE-fgl2-/- mice exhibited (as compared to AE-WT-animals) (a) a significantly lower parasite load with reduced proliferation activity, (b) an increased T cell proliferative response to ConA, (c) reduced Treg numbers and function, and (d) a persistent capacity of Th1 polarization and DC maturation.ConclusionsFGL2 appears as one of the key players in immune regulatory processes favoring metacestode survival by promoting Treg cell activity and IL-17A production that contributes to FGL2-regulation. Prospectively, targeting FGL2 could be an option to develop an immunotherapy against AE and other chronic parasitic diseases.

Highlights

  • Alveolar echinococcosis (AE) is a very severe zoonotic helminthic disease in humans, exhibiting a fatal outcome if remaining untreated [1]

  • We previously showed that Fibrinogen-like-protein 2 (FGL2), a novel CD4+CD25+ T regulatory cells (Tregs) effector molecule, was over-expressed in the liver of mice experimentally infected with E. multilocularis

  • FGL2 appears as one of the key players in immune regulatory processes favoring metacestode survival by promoting Treg cell activity and IL-17A production that contributes to FGL2regulation

Read more

Summary

Introduction

Alveolar echinococcosis (AE) is a very severe zoonotic helminthic disease in humans, exhibiting a fatal outcome if remaining untreated [1]. Experimental murine AE is characterized, as studied in spleen or lymph node cells, by an initial Th1 response during the early stage of infection (till 1 month p.i.) that gradually switches to a more dominant Th2-biased response during the chronic phase of AE (2–4 months p.i.). This mostly mixed Th1/Th2 profile, characterized by the concomitant presence of IL-12α, IFN-γ and IL-4 at the very early stage of E. multilocularis infection [4], is associated with the expression of pro-inflammatory cytokines in the periparasitic granuloma and partial/ relative protective immunity (restriction of parasite growth) through fibrosis and necrosis [5]. Little is known about its contribution to the control of this chronic helminth infection

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call